title: The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
abstract: The interaction of prolactin (PRL) with its receptor leads to activation of the tyrosine kinase, Janus kinase 2 (JAK2). In the cytoplasmic juxtamembrane region, a short segment (Box 1) which is conserved in other receptors of the PRL/growth hormone (GH)/cytokine receptor family, is required for signal transduction. To assess the contribution of the different amino acids of Box 1, individual alanine substitutions of all residues, grouped substitution of four prolines (4PA mutant) and individual leucine replacement of the two last prolines (P248L and P250L mutants) were introduced. Here we show that P250L and 4PA (i) inhibit PRL-induced transactivation of a luciferase reporter governed by a beta-caseine gene promoter; (ii) decrease in JAK2 tyrosine kinase activity in biotinylated-PRL precipitates; (iii) impair the interaction between PRLR and JAK2, as evidenced by lack of co-immunoprecipitation, (iv) and prevent the activation of signal transducer and activator of transcription (Stat) as determined by absence of tyrosine phosphorylation of Stat5. Our data suggest that the Box 1 region of the PRL receptor and particularly the last proline is critical for JAK2 association and subsequent activation. These results support the notion that the tyrosine kinase JAK2 is implicated in activation of downstream protein effectors such as Stat5, which are involved in transcription of PRL-responsive genes.
authors.affiliation: INSERM U344-Endocrinologie Moléculaire, Faculté de Medecine Necker Enfants Malades, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Pezet
authors.forename: H
authors.initials: H
authors.lastname: Buteau
authors.forename: P A
authors.initials: PA
authors.lastname: Kelly
authors.forename: M
authors.initials: M
authors.lastname: Edery
mesh_terms: D004268:DNA-Binding Proteins / Q000235:genetics*; D004789:Enzyme Activation; D005347:Fibroblasts / Q000378:metabolism; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D006801:Humans; D053614:Janus Kinase 2; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D008894:Milk Proteins; D016297:Mutagenesis, Site-Directed; D010766:Phosphorylation; D011388:Prolactin / Q000235:genetics*; D011392:Proline; D011505:Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D011518:Proto-Oncogene Proteins; D011981:Receptors, Prolactin / Q000235:genetics* / Q000378:metabolism; D050799:STAT5 Transcription Factor; D015534:Trans-Activators / Q000235:genetics*; D015533:Transcriptional Activation
chemical_list: D004268:DNA-Binding Proteins; D008894:Milk Proteins; D011518:Proto-Oncogene Proteins; D011981:Receptors, Prolactin; D050799:STAT5 Transcription Factor; D015534:Trans-Activators; D011388:Prolactin; D011392:Proline; D008156:Luciferases; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2